Continuum Advisory’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
BIP
Continuum Advisory's TAK Position: Q2 2026 in Review
Continuum Advisory opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 72 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #1832 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in TAK as recently as Q4 2024.
Continuum Advisory first reported a position in TAK in Q1 2024 and has held it in 5 quarters since. The position peaked at $13.8K in Q1 2024. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.
- Continuum Advisory held 72 shares of Takeda Pharmaceutical worth $1.15K as of Q2 2026.
- Takeda Pharmaceutical was a new Continuum Advisory position in Q2 2026.
- Takeda Pharmaceutical made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1832 holding.
- Continuum Advisory first reported a position in Takeda Pharmaceutical in Q1 2024 and has held it in 5 quarters since.
- Continuum Advisory's Takeda Pharmaceutical position peaked at $13.8K in Q1 2024.
- 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.